Madrigal Pharmaceuticals, Inc.
MDGL· Nasdaq
Released May 9, 2023, before the open
10-Q filed May 9, 2023, 39 days after period end · 0001193125-23-138863
| Metric | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$76.90M | -$57.52M | -$52.55M | -$36.14M |
| EPS Diluted |
Madrigal Pharmaceuticals, Inc. · CIK 1157601 · Engraved from SEC EDGAR
| -$4.23 |
| -$3.36 |
| -$3.32 |
| -$2.34 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.